Cargando…

Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment

BACKGROUND: To evaluate the prevalence of metastatic tumors involving the myocardium and study their presentation in order to increase awareness to their existence. METHODS: Pathological reports from Sheba Medical Center (Israel, January 1, 2010 through December 31, 2015) and medical records from Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Burazor, Ivana, Aviel-Ronen, Sarit, Imazio, Massimo, Goitein, Orly, Perelman, Marina, Shelestovich, Natalia, Radovanovic, Ninoslav, Kanjuh, Vladimir, Barshack, Iris, Adler, Yehuda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819646/
https://www.ncbi.nlm.nih.gov/pubmed/29463229
http://dx.doi.org/10.1186/s12885-018-4070-x
_version_ 1783301242118733824
author Burazor, Ivana
Aviel-Ronen, Sarit
Imazio, Massimo
Goitein, Orly
Perelman, Marina
Shelestovich, Natalia
Radovanovic, Ninoslav
Kanjuh, Vladimir
Barshack, Iris
Adler, Yehuda
author_facet Burazor, Ivana
Aviel-Ronen, Sarit
Imazio, Massimo
Goitein, Orly
Perelman, Marina
Shelestovich, Natalia
Radovanovic, Ninoslav
Kanjuh, Vladimir
Barshack, Iris
Adler, Yehuda
author_sort Burazor, Ivana
collection PubMed
description BACKGROUND: To evaluate the prevalence of metastatic tumors involving the myocardium and study their presentation in order to increase awareness to their existence. METHODS: Pathological reports from Sheba Medical Center (Israel, January 1, 2010 through December 31, 2015) and medical records from The Institute for Cardiovascular Diseases of Vojvodina, Sremska Kamenica (Serbia, 23 years period) were screened for cases of metastatic cardiac tumors. Medical, radiological and pathological data of identified cases was retrieved and reviewed. RESULTS: Out of thousands of registered cardiac surgeries we found less than a dozen cases of metastatic cardiac tumors classified as melanoma, carcinomas of lung, colon and kidney and sarcomas of uterine origin. We found that metastatic cardiac tumors comprised 15.8% of all the cardiac tumors. CONCLUSIONS: Metastatic cardiac tumors are extremely rare. As new diagnostic technologies and improved survival of oncological patients may increase the incidence of metastatic cardiac tumors in the future, awareness to their existence and knowledge of their presentation are key factors in their timely recognition.
format Online
Article
Text
id pubmed-5819646
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58196462018-02-26 Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment Burazor, Ivana Aviel-Ronen, Sarit Imazio, Massimo Goitein, Orly Perelman, Marina Shelestovich, Natalia Radovanovic, Ninoslav Kanjuh, Vladimir Barshack, Iris Adler, Yehuda BMC Cancer Research Article BACKGROUND: To evaluate the prevalence of metastatic tumors involving the myocardium and study their presentation in order to increase awareness to their existence. METHODS: Pathological reports from Sheba Medical Center (Israel, January 1, 2010 through December 31, 2015) and medical records from The Institute for Cardiovascular Diseases of Vojvodina, Sremska Kamenica (Serbia, 23 years period) were screened for cases of metastatic cardiac tumors. Medical, radiological and pathological data of identified cases was retrieved and reviewed. RESULTS: Out of thousands of registered cardiac surgeries we found less than a dozen cases of metastatic cardiac tumors classified as melanoma, carcinomas of lung, colon and kidney and sarcomas of uterine origin. We found that metastatic cardiac tumors comprised 15.8% of all the cardiac tumors. CONCLUSIONS: Metastatic cardiac tumors are extremely rare. As new diagnostic technologies and improved survival of oncological patients may increase the incidence of metastatic cardiac tumors in the future, awareness to their existence and knowledge of their presentation are key factors in their timely recognition. BioMed Central 2018-02-20 /pmc/articles/PMC5819646/ /pubmed/29463229 http://dx.doi.org/10.1186/s12885-018-4070-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Burazor, Ivana
Aviel-Ronen, Sarit
Imazio, Massimo
Goitein, Orly
Perelman, Marina
Shelestovich, Natalia
Radovanovic, Ninoslav
Kanjuh, Vladimir
Barshack, Iris
Adler, Yehuda
Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment
title Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment
title_full Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment
title_fullStr Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment
title_full_unstemmed Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment
title_short Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment
title_sort metastatic cardiac tumors: from clinical presentation through diagnosis to treatment
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819646/
https://www.ncbi.nlm.nih.gov/pubmed/29463229
http://dx.doi.org/10.1186/s12885-018-4070-x
work_keys_str_mv AT burazorivana metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment
AT avielronensarit metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment
AT imaziomassimo metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment
AT goiteinorly metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment
AT perelmanmarina metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment
AT shelestovichnatalia metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment
AT radovanovicninoslav metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment
AT kanjuhvladimir metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment
AT barshackiris metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment
AT adleryehuda metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment